IGF-DES (0.1mg)
Description
A single-component research material supplied for controlled research environments. IGF-1 DES(1-3) (0.1 mg) is a truncated analog of IGF-1 lacking the first three N-terminal amino acids (Gly-Pro-Glu), resulting in significantly reduced IGF binding protein (IGFBP) affinity and enhanced receptor bioavailability, widely used in research exploring IGF-1 receptor activation, mitogenic signaling, and growth factor potency in model systems.
Composition
-
IGF-DES (IGF-1 DES(1-3)): 0.1 mg
-
Appearance: lyophilized powder in a sealed research vial
Research Focus (non-clinical)
-
Investigation of unbound IGF-1R activation kinetics and enhanced mitogenic potency compared to full-length IGF-1 in cell culture studies
-
Evaluation of IGFBP-independent proliferative responses in in vitro and in vivo experimental models
-
Assessment of autocrine and paracrine growth factor signaling in tissue-specific model systems under controlled laboratory conditions
-
Stability and bioactivity characterization of lyophilized IGF-DES under laboratory storage conditions
Documentation
-
Lot-specific COA available
-
Batch and lot traceability
Important Notice
-
For research use only
-
Not for human consumption
-
Not intended to diagnose, treat, cure, or prevent any disease
Quality & Manufacturing
-
Lot-specific COA
-
Lyophilized for transit stability; batch traceable
-
Tamper-evident seal; lot & test date on each vial
-
No MOQ for online orders
-
Bulk orders for physical locations start at 25-unit minimum

